Omicron variant may have evolved in rats, one theory says By Nicoletta Lanese 02 December 2021 Some features of the omicron variant's genome hint that it may have evolved in rodents.
1st case of omicron variant in US confirmed in California By Yasemin Saplakoglu 01 December 2021 U.S. officials confirmed the first U.S. case of omicron in California.
Coronavirus variants: Here's how the SARS-CoV-2 mutants stack up By Live Science Staff 30 November 2021 Here's a look at the science behind SARS-CoV-2 variants and which coronavirus mutants are the most concerning in different areas.
The Omicron variant: What we know so far By Yasemin Saplakoglu 29 November 2021 On Nov. 26, the World Health Organization (WHO) named a new coronavirus variant "Omicron" and designated it as a "variant of concern."
FDA authorizes Pfizer and Moderna COVID-19 booster shots for all adults By Yasemin Saplakoglu 19 November 2021 On Friday (Nov. 19), The Food and Drug Administration (FDA) authorized Moderna and Pfizer boosters for all adults, prior to the busy holiday season.
California and Colorado start COVID-19 booster shots for all adults By Yasemin Saplakoglu 12 November 2021 California and Colorado expanded booster shot eligibility to all adults who received their second dose of Moderna's or Pfizer's COVID-19 vaccine at least six months ago.
Antiviral pill cuts COVID-19 hospitalizations and deaths by 89%, Pfizer says By Yasemin Saplakoglu 05 November 2021 A new COVID-19 pill significantly cuts risk of hospitalization or death when taken within three days of symptom onset, Pfizer says.
FDA panel recommends Pfizer vaccine for children ages 5 to 11 By Yasemin Saplakoglu 26 October 2021 The FDA panel concluded that the benefits of Pfizer's COVID-19 vaccine for young children outweigh the risks.
'Rogue' antibodies found in brains of teens with delusions and paranoia after COVID-19 By Nicoletta Lanese 25 October 2021 Autoantibodies may sometimes be involved in the psychiatric effects of COVID-19.
Moderna says COVID-19 vaccine is safe and effective in children By Yasemin Saplakoglu 25 October 2021 The company plans to submit their data to regulatory agencies soon.
Woman infected with COVID-19 for 335 days — longest on record By Yasemin Saplakoglu 21 October 2021 A woman who survived cancer was infected with the novel coronavirus for nearly a year, in the longest-ever reported case of COVID-19, according to a new study.
Should you mix and match COVID-19 vaccines? By Yasemin Saplakoglu 21 October 2021 Many people will now be able to "mix and match" COVID-19 booster shots — that is, get a different COVID-19 vaccine for a booster, the FDA announced Wednesday (Oct. 20).
Colin Powell's weakened immune system may have played a role in his COVID-19 death By Nicoletta Lanese 18 October 2021 Powell had previously undergone treatment for a blood cancer that can harm the immune system.
FDA advisory committee recommends Moderna COVID-19 vaccine booster By Yasemin Saplakoglu 14 October 2021 An advisory committee voted unanimously on Thursday (Oct. 14) to recommend a Moderna COVID-19 vaccine booster for certain groups of people.
We might finally know what causes 'COVID toes' By Nicoletta Lanese 07 October 2021 The rashes may emerge due to a runaway immune response.
Pfizer asks FDA to authorize COVID-19 vaccine for young kids By Yasemin Saplakoglu 07 October 2021 Pfizer and BioNTech officially submitted a request to the FDA to approve their COVID-19 vaccine for children aged 5 to 11.
New antiviral pill halves risk of COVID-19 hospitalization, Merck says By Nicoletta Lanese 01 October 2021 Merck announced promising trial results this week, but the full data has yet to be released.
Viruses found in Laos bats are closest known relatives to SARS-CoV-2 By Rachael Rettner 25 September 2021 Strengthening case for natural origin.
COVID-19 has now killed as many people in the U.S. as the 1918 Spanish flu By Yasemin Saplakoglu 21 September 2021 The 1918-1919 flu pandemic led to approximately 675,000 deaths in the U.S.
Pfizer says its COVID-19 vaccine is safe and effective for younger kids By Yasemin Saplakoglu 20 September 2021 A lower dose of the vaccine showed to be safe, well-tolerated and effective in spurring antibodies in kids between 5 to 11 years of age, the company announced.
